BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghrénassia E, Avouac J, Khanna D, Derk CT, Distler O, Suliman YA, Airo P, Carreira PE, Foti R, Granel B. Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study. J Rheumatol. 2014;41:99-105. [PMID: 24293584 DOI: 10.3899/jrheum.130386] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Stochmal A, Czuwara J, Trojanowska M, Rudnicka L. Antinuclear Antibodies in Systemic Sclerosis: an Update.Clin Rev Allergy Immunol. 2020;58:40-51. [PMID: 30607749 DOI: 10.1007/s12016-018-8718-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
2 Bhattacharyya A, Sahhar J, Milliken S, Ma D, Englert H, Tymms K, Danta M, Moore J. Autologous Hematopoietic Stem Cell Transplant for Systemic Sclerosis Improves Anemia from Gastric Antral Vascular Ectasia. J Rheumatol 2015;42:554-5. [DOI: 10.3899/jrheum.141234] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
3 Matsumoto Y, Hayashi H, Tahara K, Yasuda T, Tsubouchi S, Yamamoto Y, Mizuuchi T, Mori H, Sawada T. Intravenous Cyclophosphamide for Gastric Antral Vascular Ectasia Associated with Systemic Sclerosis Refractory to Endoscopic Treatment: A Case Report and Review of the Pertinent Literature. Intern Med 2019;58:135-9. [PMID: 30101944 DOI: 10.2169/internalmedicine.1431-18] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
4 Cavazzana I, Vojinovic T, Airo' P, Fredi M, Ceribelli A, Pedretti E, Lazzaroni MG, Garrafa E, Franceschini F. Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers. Clin Rev Allergy Immunol 2022. [PMID: 35716254 DOI: 10.1007/s12016-022-08946-w] [Reference Citation Analysis]
5 Hamaguchi Y, Takehara K. Anti-nuclear autoantibodies in systemic sclerosis : News and perspectives. Journal of Scleroderma and Related Disorders 2018;3:201-13. [DOI: 10.1177/2397198318783930] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Mohan C, Assassi S. Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity? BMJ 2015;351:h5079. [PMID: 26612523 DOI: 10.1136/bmj.h5079] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
7 Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390:1685-1699. [PMID: 28413064 DOI: 10.1016/s0140-6736(17)30933-9] [Cited by in Crossref: 580] [Cited by in F6Publishing: 245] [Article Influence: 116.0] [Reference Citation Analysis]
8 Saygin D, Highland KB, Tonelli AR. Microvascular involvement in systemic sclerosis and systemic lupus erythematosus. Microcirculation 2019;26:e12440. [PMID: 29323451 DOI: 10.1111/micc.12440] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Dall'Ara F, Lazzaroni MG, Antonioli CM, Airò P. Systemic sclerosis with anti-RNA polymerase III positivity following silicone breast implant rupture: possible role of B-cell depletion and implant removal in the treatment. Rheumatol Int 2017;37:847-51. [PMID: 28160072 DOI: 10.1007/s00296-017-3654-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
10 Kuwana M, Medsger TA. The Clinical Aspects of Autoantibodies. In: Varga J, Denton CP, Wigley FM, Allanore Y, Kuwana M, editors. Scleroderma. Cham: Springer International Publishing; 2017. pp. 207-20. [DOI: 10.1007/978-3-319-31407-5_15] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Chalayer E, Gramont B, Zekre F, Goguyer-Deschaumes R, Waeckel L, Grange L, Paul S, Chung AW, Killian M. Fc receptors gone wrong: A comprehensive review of their roles in autoimmune and inflammatory diseases. Autoimmun Rev 2021;21:103016. [PMID: 34915182 DOI: 10.1016/j.autrev.2021.103016] [Reference Citation Analysis]
12 Kuwana M. A To-Do List at Diagnosis of Systemic Sclerosis with Positive Anti-RNA Polymerase III Antibodies. J Rheumatol 2017;44:550-2. [DOI: 10.3899/jrheum.170037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Morrisroe K, Hansen D, Stevens W, Sahhar J, Ngian GS, Hill C, Roddy J, Walker J, Proudman S, Nikpour M. Gastric antral vascular ectasia in systemic sclerosis: a study of its epidemiology, disease characteristics and impact on survival. Arthritis Res Ther 2022;24:103. [PMID: 35538587 DOI: 10.1186/s13075-022-02790-1] [Reference Citation Analysis]
14 Shukla R, Warner R, Whorwell P, Herrick AL. Upper gastrointestinal vascular ectasia: an under-recognized complication of systemic sclerosis. Scand J Rheumatol 2021;50:325-6. [PMID: 32783483 DOI: 10.1080/03009742.2020.1794029] [Reference Citation Analysis]
15 Grant MJ, Horwitz ME. HSCT-GAVE as a Manifestation of Chronic Graft versus Host Disease: A Case Report and Review of the Existing Literature. Case Rep Transplant 2018;2018:2376483. [PMID: 29721346 DOI: 10.1155/2018/2376483] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Braun-Moscovici Y, Brun R, Braun M. Systemic Sclerosis and the Gastrointestinal Tract-Clinical Approach. Rambam Maimonides Med J. 2016;7. [PMID: 27824553 DOI: 10.5041/rmmj.10258] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
17 Nagaraja V, Matucci-Cerinic M, Furst DE, Kuwana M, Allanore Y, Denton CP, Raghu G, Mclaughlin V, Rao PS, Seibold JR, Pauling JD, Whitfield ML, Khanna D. Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis. Arthritis Rheumatol 2020;72:1049-58. [PMID: 32134199 DOI: 10.1002/art.41246] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
18 Corrado A, Correale M, Mansueto N, Monaco I, Carriero A, Mele A, Colia R, Di Biase M, Cantatore FP. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension. Microvasc Res 2017;114:46-51. [PMID: 28619664 DOI: 10.1016/j.mvr.2017.06.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
19 Kang EH, Ha YJ, Lee YJ. Autoantibody Biomarkers in Rheumatic Diseases. Int J Mol Sci 2020;21:E1382. [PMID: 32085664 DOI: 10.3390/ijms21041382] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Berger M, Steen VD. Role of anti-receptor autoantibodies in pathophysiology of scleroderma. Autoimmun Rev 2017;16:1029-35. [PMID: 28778706 DOI: 10.1016/j.autrev.2017.07.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
21 Benvenuti F, Zanatta E, Avouac J, Müller-ladner U, Cozzi F, Hoffmann-vold A, Gabrielli A, Distler O, Matucci-cerinic M, Allanore Y, Doria A. The power of the EUSTAR cohort: key findings to date and implications for management of systemic sclerosis patients. Expert Review of Clinical Immunology 2020;16:1065-74. [DOI: 10.1080/1744666x.2021.1836962] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Becker MO, Riemekasten G. Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course. Expert Rev Clin Immunol 2016;12:115-35. [PMID: 26558747 DOI: 10.1586/1744666X.2016.1115717] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]
23 Peng M, Guo X, Yi F, Romeiro FG, Mancuso A, Qi X. Pharmacotherapy for the Treatment of Gastric Antral Vascular Ectasia: A Narrative Review. Adv Ther 2021;38:5065-77. [PMID: 34524644 DOI: 10.1007/s12325-021-01912-6] [Reference Citation Analysis]
24 Schioppo T, Ingegnoli F. Current perspective on rituximab in rheumatic diseases. Drug Des Devel Ther 2017;11:2891-904. [PMID: 29042750 DOI: 10.2147/DDDT.S139248] [Cited by in Crossref: 46] [Cited by in F6Publishing: 17] [Article Influence: 9.2] [Reference Citation Analysis]
25 Cleac’h AL, Villeneuve J, Sylvestre M, Huard G, Giard J, Ditisheim S. Gastric antral vascular ectasia is more frequent in patients with non-alcoholic steatohepatitis-induced cirrhosis. CanLivJ 2019;2:84-90. [DOI: 10.3138/canlivj.2018-0021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Wang J, Stine JG, Cornella SL, Argo CK, Cohn SM. Patients with Gastric Antral Vascular Ectasia (GAVE) Are at a Higher Risk of Gastrointestinal Bleeding in the Absence of Cirrhosis. J Clin Transl Hepatol 2015;3:254-9. [PMID: 26807380 DOI: 10.14218/JCTH.2015.00031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
27 Turrión Nieves AI, Moruno Cruz H, Romero Bogado ML, Perez Gómez A. Upper gastrointestinal bleeding (watermelon stomach) in a patient with limited scleroderma (CREST syndrome). Reumatol Clin 2017;13:361-2. [PMID: 27353193 DOI: 10.1016/j.reuma.2016.05.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Lazzaroni M, Airò P. Anti-RNA polymerase III antibodies in patients with suspected and definite systemic sclerosis: Why and how to screen. Journal of Scleroderma and Related Disorders 2018;3:214-20. [DOI: 10.1177/2397198318786158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Bartosik I, Andréasson K, Starck M, Scheja A, Hesselstrand R. Vascular events are risk factors for anal incontinence in systemic sclerosis: a study of morphology and functional properties measured by anal endosonography and manometry. Scand J Rheumatol 2014;43:391-7. [PMID: 24720395 DOI: 10.3109/03009742.2014.889210] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
30 Domsic RT, Medsger TA. Autoantibodies and Their Role in Scleroderma Clinical Care. Curr Treat Options in Rheum 2016;2:239-51. [DOI: 10.1007/s40674-016-0050-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
31 Matsushita T, Takehara K. An update on biomarker discovery and use in systemic sclerosis. Expert Review of Molecular Diagnostics 2017;17:823-33. [DOI: 10.1080/14737159.2017.1356722] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
32 Marie I, Antonietti M, Houivet E, Hachulla E, Maunoury V, Bienvenu B, Viennot S, Smail A, Duhaut P, Dupas JL, Dominique S, Hatron PY, Levesque H, Benichou J, Ducrotté P. Gastrointestinal mucosal abnormalities using videocapsule endoscopy in systemic sclerosis. Aliment Pharmacol Ther 2014;40:189-99. [PMID: 24889779 DOI: 10.1111/apt.12818] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
33 Emmanuel A. Current management of the gastrointestinal complications of systemic sclerosis. Nat Rev Gastroenterol Hepatol. 2016;13:461-472. [PMID: 27381075 DOI: 10.1038/nrgastro.2016.99] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
34 El-Gendy H, Shohdy KS, Maghraby GG, Abadeer K, Mahmoud M. Gastric antral vascular ectasia in systemic sclerosis: Where do we stand? Int J Rheum Dis 2017;20:2133-9. [PMID: 28217887 DOI: 10.1111/1756-185X.13047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
35 Elhai M, Avouac J, Kahan A, Allanore Y. Systemic sclerosis: Recent insights. Joint Bone Spine 2015;82:148-53. [PMID: 25557659 DOI: 10.1016/j.jbspin.2014.10.010] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
36 Parrado RH, Lemus HN, Coral-alvarado PX, Quintana López G. Gastric Antral Vascular Ectasia in Systemic Sclerosis: Current Concepts. International Journal of Rheumatology 2015;2015:1-6. [DOI: 10.1155/2015/762546] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
37 Lazzaroni MG, Cavazzana I, Colombo E, Dobrota R, Hernandez J, Hesselstrand R, Varju C, Nagy G, Smith V, Caramaschi P, Riccieri V, Hachulla E, Balbir-Gurman A, Chatelus E, Romanowska-Próchnicka K, Araújo AC, Distler O, Allanore Y, Airò P; EUSTAR co-authors. Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening. J Rheumatol 2017;44:639-47. [PMID: 28089973 DOI: 10.3899/jrheum.160817] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 10.6] [Reference Citation Analysis]
38 Hudson M. Scleroderma renal crisis. Curr Opin Rheumatol 2015;27:549-54. [PMID: 26352732 DOI: 10.1097/BOR.0000000000000221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
39 Kirby DF, Chatterjee S. Evaluation and management of gastrointestinal manifestations in scleroderma. Curr Opin Rheumatol. 2014;26:621-629. [PMID: 25207461 DOI: 10.1097/bor.0000000000000117] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
40 Shreiner AB, Murray C, Denton C, Khanna D. Gastrointestinal Manifestations of Systemic Sclerosis. J Scleroderma Relat Disord. 2016;1:247-256. [PMID: 28133631 DOI: 10.5301/jsrd.5000214] [Cited by in Crossref: 61] [Cited by in F6Publishing: 46] [Article Influence: 10.2] [Reference Citation Analysis]
41 Asai A, Banno S, Asai N, Ito M, Sugiyama H, Yamaguchi M, Iwagaitsu S, Nobata H, Kinasi H, Katsuno T, Ito Y. Diffuse alveolar haemorrhage in a case with anti-RNA polymerase III antibody-positive systemic sclerosis successfully treated with plasma exchange and corticosteroid therapy. Mod Rheumatol Case Rep 2020;4:51-5. [PMID: 33086969 DOI: 10.1080/24725625.2019.1680137] [Reference Citation Analysis]
42 Assad APL, Farias R, Gaspari CN, da Silva HC, Andrade DCO, Sampaio-Barros PD. Diagnosis and Management of Gastric Antral Vascular Ectasia: Experience in a Large Single Cohort of Patients With Systemic Sclerosis. J Clin Rheumatol 2020;26:79-81. [PMID: 32073520 DOI: 10.1097/RHU.0000000000000927] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Utsunomiya A, Oyama N, Hasegawa M. Potential Biomarkers in Systemic Sclerosis: A Literature Review and Update. J Clin Med 2020;9:E3388. [PMID: 33105647 DOI: 10.3390/jcm9113388] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
44 Steen VD. Kidney involvement in systemic sclerosis. Presse Med 2014;43:e305-14. [PMID: 25174767 DOI: 10.1016/j.lpm.2014.02.031] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
45 Kavian N, Batteux F. Macro- and microvascular disease in systemic sclerosis. Vascul Pharmacol. 2015;71:16-23. [PMID: 26044180 DOI: 10.1016/j.vph.2015.05.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
46 Clarke JO, Pandolfino JE. Upper Gastrointestinal Tract: Manifestations of Systemic Sclerosis. In: Varga J, Denton CP, Wigley FM, Allanore Y, Kuwana M, editors. Scleroderma. Cham: Springer International Publishing; 2017. pp. 427-41. [DOI: 10.1007/978-3-319-31407-5_30] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
47 Stein J, Connor S, Virgin G, Ong DEH, Pereyra L. Anemia and iron deficiency in gastrointestinal and liver conditions. World J Gastroenterol 2016; 22(35): 7908-7925 [PMID: 27672287 DOI: 10.3748/wjg.v22.i35.7908] [Cited by in CrossRef: 58] [Cited by in F6Publishing: 40] [Article Influence: 9.7] [Reference Citation Analysis]
48 Papachristos DA, Nikpour M, Hair C, Stevens WM. Intravenous cyclophosphamide as a therapeutic option for severe refractory gastric antral vascular ectasia in systemic sclerosis. Intern Med J 2015;45:1077-81. [PMID: 26429218 DOI: 10.1111/imj.12883] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
49 Serling-Boyd N, Chung MP, Li S, Becker L, Fernandez-Becker N, Clarke J, Fiorentino D, Chung L. Gastric antral vascular ectasia in systemic sclerosis: Association with anti-RNA polymerase III and negative anti-nuclear antibodies. Semin Arthritis Rheum 2020;50:938-42. [PMID: 32906028 DOI: 10.1016/j.semarthrit.2020.06.016] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]